Synonyms: Coxistac® | Procoxacin®
Compound class:
Synthetic organic
|
|
References |
1. Antoszczak M, Huczyński A. (2015)
Anticancer Activity of Polyether Ionophore-Salinomycin. Anticancer Agents Med Chem, 15 (5): 575-91. [PMID:25553435] |
2. Antoszczak M, Maj E, Napiórkowska A, Stefańska J, Augustynowicz-Kopeć E, Wietrzyk J, Janczak J, Brzezinski B, Huczyński A. (2014)
Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides. Molecules, 19 (12): 19435-59. [PMID:25429565] |
3. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES. (2009)
Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 138 (4): 645-659. [PMID:19682730] |
4. Huczynski A. (2012)
Salinomycin: a new cancer drug candidate. Chem Biol Drug Des, 79 (3): 235-8. [PMID:22145602] |
5. Ianevski A, Yao R, Fenstad MH, Biza S, Zusinaite E, Reisberg T, Lysvand H, Løseth K, Landsem VM, Malmring JF et al.. (2020)
Potential Antiviral Options against SARS-CoV-2 Infection. Viruses, 12 (6). [PMID:32545799] |